Stock LALPATHLAB DR. LAL PATHLABS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Dr. Lal PathLabs Limited

Equities

LALPATHLAB

INE600L01024

Market Closed - NSE India S.E.
Other stock markets
 07:43:52 2024-05-22 am EDT 		5-day change 1st Jan Change
2,586 INR +1.16% Intraday chart for Dr. Lal PathLabs Limited +3.79% +0.32%
May. 14 Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 MT
May. 13 Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6% MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505
MT
Nomura Adjusts Dr. Lal Pathlabs’ Price Target to INR2,505 From INR2,465, Keeps at Neutral
MT
Nomura Upgrades Dr. Lal Pathlabs to Neutral From Reduce, Adjusts Price Target to INR2,465 From INR,2002
MT
Nomura Downgrades Dr. Lal Pathlabs to Reduce From Neutral, Adjusts Price Target to INR2,002 From INR1,835
MT
Nomura Adjusts Dr. Lal PathLabs' Price Target to INR1,835 From INR1,864, Keeps at Neutral
MT
Nomura Upgrades Dr. Lal PathLabs to Neutral From Reduce, Adjusts Price Target to INR1,864 From INR1,819
MT
CARE Assigns AA Rating on Dr. Lal Pathlabs' Long-term Bank Financing; Outlook Stable
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LALPATHLAB Stock
  4. News Dr. Lal PathLabs Limited
  5. Analyst Reco.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW